ARCHIVES

Clinical Trials: Phase I Trial of Karenitecin Begins, BioNumerik Says

This article is from The Cancer Letter archive.

Vol. 25 No. 09 | March 5, 1999

Download PDF Visit The Full Archive

Related Articles

NeoRx Suspends Accrual, Treatment In Phase III trial Using STR For Myeloma.

December 1, 2000

Cancer Letter, PR Firm Settle Out Of Court On Copyright Violation

November 27, 1987

Cancergrams Cost $840 Year For All

December 2, 1977

In Brief: Cancer Program “Greatest Experiment And it Works,” ACS President tells Congress

June 25, 1976

Avon Awards $16.2 Million To Cancer Centers, Others.

April 6, 2001

HEW Ruling Limits Distribution Of Chemicals From Repository To Contractors, Government

May 7, 1976